Theranexus (EPA:ALTHX)

BRIEF

published on 07/09/2026 at 18:05, 18 days 10 hours ago

THX Pharma maintains its financial stability as of June 30, 2026

Treasury Phase 3 TX01 THX Pharma Biocodex
BRIEF

published on 07/09/2026 at 18:05, 18 days 10 hours ago

THX Pharma Announces June 2026 Cash Position

Cash Position Phase 3 Study Batten Disease Niemann-Pick Disease THX Pharma
PRESS RELEASE

published on 07/09/2026 at 18:00, 18 days 10 hours ago

THX Pharma Reports Cash Position as of June 30, 2026
THX Pharma (Theranexus) announces cash position of €17.5 million as of June 30, 2026. Biocodex funds clinical development costs for Batten-1 program. Positive milestones achieved in 2026 towards commercialization

Cash Position Commercialization THX Pharma Biocodex Batten-1 Program
BRIEF

published on 06/23/2026 at 18:05, 1 month 4 days ago

THX Pharma Welcomes Sophie Jacq Lapointe to its Board of Directors

Board Of Directors Pharmaceutical Strategy THX Pharma International Marketing Sophie Jacq Lapointe
BRIEF

published on 06/23/2026 at 18:05, 1 month 4 days ago

THX Pharma Appoints Sophie Jacq Lapointe to Board of Directors

Board Of Directors Rare Diseases Pharmaceutical Strategy THX Pharma Sophie Jacq Lapointe
PRESS RELEASE

published on 06/23/2026 at 18:00, 1 month 4 days ago

THX Pharma Announces the Appointment of Sophie Jacq Lapointe to its Board of Directors
Sophie Jacq Lapointe, an experienced leader in pharmaceuticals and biotechnology, joins THX Pharma's Board of Directors to drive growth and development of rare disease treatments

Biotechnology Pharmaceutical Rare Diseases THX Pharma Sophie Jacq Lapointe
BRIEF

published on 06/16/2026 at 08:05, 1 month 11 days ago

THX Pharma: Allinvest Securities Recommends Buying the Stock

Strategic Partnerships Biopharmaceutical Rare Diseases AllInvest Securities THX Pharma
BRIEF

published on 06/16/2026 at 08:05, 1 month 11 days ago

Allinvest Securities Backs THX Pharma with Optimistic Buy Recommendation

Buy Recommendation Partnerships Rare Diseases AllInvest Securities THX Pharma
PRESS RELEASE

published on 06/16/2026 at 08:00, 1 month 11 days ago

Allinvest Securities Initiates Analyst Coverage on THX Pharma with Buy Recommendation
THX Pharma (Theranexus) announces analyst coverage by Allinvest Securities recognizing successful transformation into rare-disease platform with buy recommendation and 226% upside potential. Portzamparc also follows THX Pharma

Biopharmaceutical Analyst Coverage Rare Diseases AllInvest Securities THX Pharma
BRIEF

published on 06/09/2026 at 18:05, 1 month 18 days ago

THX Pharma and Exeltis receive a positive opinion from the EMA for TX01

PUMA Niemann-Pick C Exeltis THX Pharma PIP

Published on 07/28/2026 at 03:10, 1 hour 32 minutes ago

30 June 2026 Quarterly Activities Report
Published on 07/28/2026 at 03:05, 1 hour 37 minutes ago

Mining Exploration Entity or Oil And Gas Exploration Entity Quarterly Cash Flow Report
Published on 07/28/2026 at 03:00, 1 hour 42 minutes ago

Storm Announces Closing of Oversubscribed $2.95M Private Placement
Published on 07/27/2026 at 14:00, 14 hours 42 minutes ago

Silver Storm Announces First Concentrate Shipment from La Parrilla
Published on 07/27/2026 at 13:30, 15 hours 12 minutes ago

International Battery Metals Announces CEO Transition

View all ACCESSWIRE

Published on 07/27/2026 at 23:05, 5 hours 36 minutes ago

Quantinuum to Report Second Quarter Financial Results on August 11, 2026
Published on 07/27/2026 at 22:45, 5 hours 56 minutes ago

EQS-Adhoc: Hypoport SE: Gross profit growth and significant increase in EBIT in H1/26
Published on 07/27/2026 at 21:15, 7 hours 26 minutes ago

Xryma Plc announces the upcoming launch of XrymaCoin (XREUR), the regulated euro stablecoin designed to work like money
Published on 07/27/2026 at 20:50, 7 hours 52 minutes ago

Pentixapharm Completes Capital Increase – New Shares Placed in Full
Published on 07/27/2026 at 20:40, 8 hours 1 minute ago

EQS-Adhoc: Pentixapharm Holding AG completes rights offering and private placement with significant oversubscription generating gross proceeds of approx. EUR 20.4 Million already today

View all EQS

Published on 07/27/2026 at 18:00, 10 hours 42 minutes ago

Saint-Gobain accelerates in Asia with two targeted acquisitions
Published on 07/27/2026 at 17:45, 10 hours 57 minutes ago

Weekly share buyback
Published on 07/27/2026 at 17:40, 11 hours 2 minutes ago

260727 BENETEAU Revenue H1 2026 EN
Published on 07/27/2026 at 08:45, 19 hours 57 minutes ago

Baikowski: 2026 first-half business
Published on 07/27/2026 at 08:29, 20 hours 13 minutes ago

FREY H1 2026: a platform geared towards a new phase of growth

View all LES ECHOS COMFI WIRE

News